Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02139202 · ClinicalTrials.gov registry record · NA
Heartstrong Pilot Program
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02139202: Completed NA study, sponsored by University of Pennsylvania.
NCT02139202 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02139202, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a 6-month pilot study intended to test the effect of financial incentives on improving medication adherence in AMI patients; to test the effect on adherence of removing financial incentives; and to test the effect on the enrollment rate of modifying recruitment procedures.
Primary Outcome
Primary outcomes will be recruitment uptake of patients discharged with recent AMI from the UPHS.
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Social Influence
- BEHAVIORAL Electronic Pill Bottles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT02139202 record still lists
NCT02139202 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Financial Incentives is the first listed.
NCT02139202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02139202 about?
NCT02139202 is a clinical study titled "Heartstrong Pilot Program". This is a 6-month pilot study intended to test the effect of financial incentives on improving medication adherence in AMI patients; to test the effect on adherence of removing financial incentives; and to test the effect on the enrollment rate of modifying recruitment procedures.
What is the current status of trial NCT02139202?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02139202?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Social Influence (BEHAVIORAL), Electronic Pill Bottles (BEHAVIORAL).
Who is sponsoring clinical trial NCT02139202?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02139202's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia